Masimo Revenue 2010-2024 | MASI

Masimo annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Masimo revenue for the quarter ending September 30, 2024 was $0.505B, a 5.37% increase year-over-year.
  • Masimo revenue for the twelve months ending September 30, 2024 was $2.043B, a 3.48% decline year-over-year.
  • Masimo annual revenue for 2023 was $2.048B, a 0.6% increase from 2022.
  • Masimo annual revenue for 2022 was $2.036B, a 64.28% increase from 2021.
  • Masimo annual revenue for 2021 was $1.239B, a 8.35% increase from 2020.
Masimo Annual Revenue
(Millions of US $)
2023 $2,048
2022 $2,036
2021 $1,239
2020 $1,144
2019 $938
2018 $858
2017 $790
2016 $713
2015 $630
2014 $587
2013 $547
2012 $493
2011 $439
2010 $405
2009 $349
Masimo Quarterly Revenue
(Millions of US $)
2024-09-30 $505
2024-06-30 $496
2024-03-31 $493
2023-12-31 $549
2023-09-30 $479
2023-06-30 $455
2023-03-31 $565
2022-12-31 $617
2022-09-30 $549
2022-06-30 $565
2022-03-31 $304
2021-12-31 $328
2021-09-30 $307
2021-06-30 $305
2021-03-31 $299
2020-12-31 $295
2020-09-30 $278
2020-06-30 $301
2020-03-31 $270
2019-12-31 $248
2019-09-30 $229
2019-06-30 $230
2019-03-31 $232
2018-12-31 $223
2018-09-30 $211
2018-06-30 $212
2018-03-31 $213
2017-12-31 $208
2017-09-30 $193
2017-06-30 $192
2017-03-31 $197
2016-12-31 $201
2016-09-30 $168
2016-06-30 $173
2016-03-31 $171
2015-12-31 $167
2015-09-30 $153
2015-06-30 $156
2015-03-31 $155
2014-12-31 $162
2014-09-30 $144
2014-06-30 $141
2014-03-31 $140
2013-12-31 $142
2013-09-30 $131
2013-06-30 $137
2013-03-31 $136
2012-12-31 $132
2012-09-30 $119
2012-06-30 $123
2012-03-31 $119
2011-12-31 $112
2011-09-30 $104
2011-06-30 $110
2011-03-31 $113
2010-12-31 $106
2010-09-30 $101
2010-06-30 $100
2010-03-31 $99
2009-12-31 $93
2009-09-30 $87
2009-06-30 $84
2009-03-31 $85
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.091B $2.048B
Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.480B 24.70
Intuitive Surgical (ISRG) United States $196.045B 102.50
Alcon (ALC) Switzerland $42.794B 28.63
Edwards Lifesciences (EW) United States $42.188B 26.79
IQVIA Holdings (IQV) United States $36.777B 20.26
IDEXX Laboratories (IDXX) United States $35.676B 42.01
DexCom (DXCM) United States $30.357B 45.72
Waters (WAT) United States $22.803B 33.72
STERIS (STE) Ireland $21.310B 24.53
SONOVA HOLDING (SONVY) Switzerland $20.157B 0.00
Hologic (HOLX) United States $17.098B 18.47
Fresenius Medical Care AG KGaA (FMS) Germany $14.119B 14.49
Sysmex ADR (SSMXY) Japan $13.255B 0.00
Globus Medical (GMED) United States $11.345B 28.73
Penumbra (PEN) United States $9.105B 89.18
Teleflex (TFX) United States $8.576B 13.68
Glaukos (GKOS) United States $7.735B 0.00
PROCEPT BioRobotics (PRCT) United States $4.949B 0.00
Integer Holdings (ITGR) United States $4.675B 26.50
Veracyte (VCYT) United States $3.420B 102.63
Inari Medical (NARI) United States $2.990B 0.00
LivaNova (LIVN) United Kingdom $2.699B 15.58
Nihon Kohden (NHNKY) Japan $2.361B 17.93
TransMedics (TMDX) United States $2.291B 72.62
Elekta AB (EKTAY) Sweden $2.165B 19.47
Tandem Diabetes Care (TNDM) United States $1.978B 0.00
Integra LifeSciences Holdings (IART) United States $1.860B 9.72
RxSight (RXST) United States $1.739B 0.00
Alphatec Holdings (ATEC) United States $1.365B 0.00
Artivion (AORT) United States $1.243B 82.39
Pulse Biosciences (PLSE) United States $1.215B 0.00
OPKO Health (OPK) United States $1.085B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.849B 14.43
Paragon 28 (FNA) United States $0.840B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.712B 0.00
IRadimed (IRMD) United States $0.687B 37.11
Mesa Laboratories (MLAB) United States $0.674B 15.88
AxoGen (AXGN) United States $0.656B 0.00
SiBone (SIBN) United States $0.567B 0.00
OrthoPediatrics (KIDS) United States $0.561B 0.00
Pacific Biosciences Of California (PACB) United States $0.556B 0.00
Semler Scientific (SMLR) United States $0.512B 30.12
Treace Medical Concepts (TMCI) United States $0.494B 0.00
Tactile Systems Technology (TCMD) United States $0.439B 23.75
Delcath Systems (DCTH) United States $0.380B 0.00
ClearPoint Neuro (CLPT) United States $0.372B 0.00
NeuroPace (NPCE) United States $0.337B 0.00
CVRx (CVRX) United States $0.327B 0.00
AngioDynamics (ANGO) United States $0.284B 0.00
Inogen (INGN) United States $0.226B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Accuray (ARAY) United States $0.202B 0.00
Sight Sciences (SGHT) United States $0.196B 0.00
KORU Medical Systems (KRMD) United States $0.174B 0.00
Nevro (NVRO) United States $0.157B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.145B 15.49
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
Vicarious Surgical (RBOT) United States $0.095B 0.00
WORK Medical Technology Group (WOK) China $0.092B 0.00
LENSAR (LNSR) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
908 Devices (MASS) United States $0.080B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.054B 0.00
Lucid Diagnostics (LUCD) United States $0.050B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.039B 0.00
Neuronetics (STIM) United States $0.039B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.024B 0.00
NexGel (NXGL) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00